HAEM5:Plasma cell myeloma / multiple myeloma: Difference between revisions
| [pending revision] | [pending revision] |
Zhenya.Tang (talk | contribs) |
Zhenya.Tang (talk | contribs) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 18: | Line 18: | ||
*Zhenya Tang, MD, PhD<sup>2</sup> | *Zhenya Tang, MD, PhD<sup>2</sup> | ||
<sup>1</sup> | <sup>1</sup> Department of Laboratory Medicine, Clinical Center, National Institutes of Health (NIH), Cohort Analytics Core (CAC), National Human Genome Research Institute (NHGRI), NIH | ||
2 University of Nebraska Medical Center, Department of Pathology, Microbiology and Immunology, Omaha, Nebraska | <sup>2</sup> University of Nebraska Medical Center, College of Medicine, Department of Pathology, Microbiology and Immunology, Omaha, Nebraska | ||
==WHO Classification of Disease== | ==WHO Classification of Disease== | ||